<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): September 8, 2000
Chiron Corporation
--------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
Delaware 0-12798 94-2754624
--------------------------------------------------------------------------------
(State or other (Commission (IRS Employer
jurisdiction of File Number) Identification No.)
incorporation)
4560 Horton Street, Emeryville, CA 94608
--------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (510) 655-8730
N/A
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
ITEM 5. OTHER EVENTS.
Chiron Corporation announced on September 8, 2000 that the Company would call
for redemption all of its $243.8 million, 1.90% convertible subordinated
debentures due November 17, 2000, of which amount the public holds $243,800,000
and Novartis AG holds $10,069,000 (the "1.90% Debentures"). The redemption date
for the 1.90% Debentures is October 11, 2000.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
(c) Exhibits.
EXHIBIT NUMBER
99.1 Press release by Chiron Corporation dated September 8, 2000 relating to
Registrant's call for redemption of all of its 1.90%
convertible subordinated debentures, referred to in Item 5 above.
99.2 Registrant's Notification of call for redemption to State Street Bank
and Trust Company of California, N.A., as successor trustee to The
First National Bank of Boston, as Trustee, dated September 1, 2000.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
CHIRON CORPORATION
Date: September 8, 2000 By: /s/ WILLIAM G. GREEN
------------------------
William G. Green
Senior Vice President,
General Counsel and
Secretary
3
